Breaks Categories: News

ThursdayJul 13, 2017 11:59 am

NetworkNewsBreaks – Great Basin Scientific, Inc.’s (GBSN) Stool Bacterial Pathogens Panel Obtains FDA 510(k) Clearance

Shares of Great Basin Scientific (OTCQB: GBSN) are up 7% mid-day on news that the company has received U. S. Food and Drug Administration (FDA) 510(k) clearance for its Stool Bacterial Pathogens Panel (SBPP). FDA clearance now allows the company to begin actively marketing SBPP to its current customer base of over 230 hospitals and labs, as well as new customers. “We are excited to begin actively marketing this panel, which is priced below likely reimbursement rates, and expect demand for SBPP to add additional revenue for the company, with significant revenue growth from the product expected later in 2017…

Continue Reading

ThursdayJul 13, 2017 11:44 am

NetworkNewsBreaks – American Energy Partners, Inc. (XFUL) Featured in Exclusive Audio Interview by NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire (“NNW”) this morning announced the online availability of an exclusive audio interview with diversified energy company Converde Energy USA (OTC: XFUL), doing business as American Energy Partners, Inc. In the interview, Josh C. Hickman, president of the company’s Gilbert Oil & Gas, LLC, subsidiary, gives listeners insight into XFUL’s corporate history, as well as its ongoing efforts to capitalize on growing markets, such as the market for water ownership. “It is excellent to be in the position that I am with Gilbert and with American Energy Partners,” Hickman noted in the NNW interview.…

Continue Reading

WednesdayJul 12, 2017 12:06 pm

NetworkNewsBreaks – ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) Lists Common Shares on OTCQB Venture Market and Frankfurt Stock Exchange

ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) this morning announced that its common shares have been approved for trading on the OTCQB Venture Market, under the symbol ‘ABCCF’, and on the Frankfurt Stock Exchange, under the symbol ‘23Q’. The company’s common shares will also continue to trade on the TSX Venture Exchange under the symbol ‘ABCN’. The company expects that these listings will provide a number of long-term benefits, including greater visibility and convenience for investors in the United States and Europe. As a result of this expanded base of potential shareholders, ABcann will likely benefit from enhanced liquidity moving…

Continue Reading

WednesdayJul 12, 2017 9:31 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) CEO Issues Letter to Shareholders

Global financial technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) this morning released an updated letter to shareholders from CEO Oleg Firer. In the update, he recaps the company’s achievements for the first half of the year before taking a look at recent corporate events that could contribute to Net Element’s future performance. “To date, our focus has been on growing our business and creating an efficient, well-functioning company by laying the foundation for a scalable business,” Firer noted in the shareholder letter. “I am pleased to say that we have been successful in the execution of these…

Continue Reading

TuesdayJul 11, 2017 12:57 pm

NetworkNewsBreaks – Cascadian Therapeutics, Inc. (NASDAQ: CASC) Reports Positive Regulatory Update for Tucatinib in Europe Following EMA Discussion

Cascadian Therapeutics (NASDAQ: CASC) this morning reported a positive outcome from recent discussions with the European Medicines Agency (EMA) regarding the development of the company’s investigational medicine for the treatment of HER2-positive metastatic breast cancer, tucatinib. The company has received validating news that if the ongoing pivotal trial of tucatinib known as HER2CLIMB demonstrates positive results, it could serve as a single registrational trial for submission of a Marketing Authorization Application (MAA) to the EMA and potential marketing approval. Cascadian received a similar confirmation from the FDA last year. “This is an important milestone for the company. We had anticipated…

Continue Reading

TuesdayJul 11, 2017 12:54 pm

NetworkNewsBreaks – ArQule, Inc. (NASDAQ: ARQL) Doses First Patient in Phase 1 Trial of ARQ 531 for B-cell Malignancies

ArQule (NASDAQ: ARQL) this morning said that the first patient has been dosed in its phase 1a/b trial with ARQ 531 in patients with B-cell malignancies that do not respond well to other approved therapies. ARQ 531 is an investigational, orally bioavailable, potent and reversible inhibitor of both wild type and C481S-mutant Bruton’s tyrosine kinase (BTK). The phase 1a portion of the trial aims to establish a recommended dose through a dose escalation study open to all refractory patients. The company’s goal for the phase 1b portion will be to establish proof of concept and early signs of activity. “Our…

Continue Reading

TuesdayJul 11, 2017 12:10 pm

NetworkNewsBreaks – NXT-ID, Inc.’s (NASDAQ: NXTD) Fit Pay Subsidiary Reveals New FitPay Prepaid MasterCard®

Shares of NXT-ID, Inc. (NASDAQ: NXTD) are 6% higher mid-day on news that the company’s wholly-owned subsidiary, Fit Pay, Inc., will offer prepaid capabilities on wearable devices connected to the Fit Pay Payment Platform. 'The FitPay Prepaid MasterCard®' will store funds directly on user’s contactless payment-enabled device, and a digital wallet will allow the user to re-load the account, set top-off thresholds and manage the account settings. The FitPay Prepaid MasterCard® option will be available to device OEMs that integrate their products with the Fit Pay platform. "Adding reloadable prepaid capabilities is a new feature for devices on our platform…

Continue Reading

TuesdayJul 11, 2017 12:08 pm

NetworkNewsBreaks – ReWalk Robotics (NASDAQ: RWLK) Inks Exclusive French Distribution Agreement with Harmonie Médical Service; Shares Climb

ReWalk Robotics (NASDAQ: RWLK) shares are 8% higher after the company this morning said it has signed a new, exclusive distribution agreement in France with Harmonie Médical Service (HMS). HMS is a well-established health service provider with branches throughout France. Per the agreement, HMS be the sole distributor of ReWalk exoskeleton systems to qualifying candidates with spinal cord injury (SCI) in France. "As the product is now available for everyday use at home and in the community, HMS provides the resources, support structure and quality as a leading provider of products for injured individuals,” ReWalk Robotics Chief Commercial Officer Jodi…

Continue Reading

TuesdayJul 11, 2017 8:54 am

NetworkNewsBreaks – ORHub, Inc. (ORHB) Eyes Expansion in Major US Markets with Entry into National Deployment Agreement

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) this morning announced its agreement with a national deployment partner to manage the deployment, implementation and scaling of the ORHub Surgical Resource Management Platform in hospitals that serve 10 major U.S. metropolitan markets. “We are excited to partner with one of the most elite health care consulting firms in the country,” Colt Melby, CEO of ORHub, stated in the news release. “This partnership gives ORHub immediate reach into a national delivery infrastructure, allowing us to focus on advancing our software and analytics platform while helping more hospitals and surgeons make better real-time,…

Continue Reading

MondayJul 10, 2017 11:24 am

NetworkNewsBreaks – ORHub, Inc. (ORHB) Software Highlighted in Microsoft Publication

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced the availability of a Microsoft publication highlighting the company’s surgical resource management (SRM) solution, which is in use at the Hoag Orthopedic Institute in Irvine, California. The case study, titled “Orthopedic hospital tests cloud-based cure for symptoms of rising healthcare costs,” discusses Hoag’s experience using ORHub’s software as an actionable resource analytics tool for its spinal surgeries. Notably, the cloud-based software, which is accessed directly in the operating room, supports improved teamwork, automates manual processes and streamlines resource allocation in the face of rising health care costs. “We've seen from…

Continue Reading